NUMBER: standardized reference intervals in the Netherlands using a ‘big data’ approach

Abstract Background External quality assessment (EQA) programs for general chemistry tests have evolved from between laboratory comparison programs to trueness verification surveys. In the Netherlands, the implementation of such programs has reduced inter-laboratory variation for electrolytes, substrates and enzymes. This allows for national and metrological traceable reference intervals, but these are still lacking. We have initiated a national endeavor named NUMBER (Nederlandse UniforMe Beslisgrenzen En Referentie-intervallen) to set up a sustainable system for the determination of standardized reference intervals in the Netherlands. Methods We used an evidence-based ‘big-data’ approach to deduce reference intervals using millions of test results from patients visiting general practitioners from clinical laboratory databases. We selected 21 medical tests which are either traceable to SI or have Joint Committee for Traceability in Laboratory Medicine (JCTLM)-listed reference materials and/or reference methods. Per laboratory, per test, outliers were excluded, data were transformed to a normal distribution (if necessary), and means and standard deviations (SDs) were calculated. Then, average means and SDs per test were calculated to generate pooled (mean±2 SD) reference intervals. Results were discussed in expert meetings. Results Sixteen carefully selected clinical laboratories across the country provided anonymous test results (n=7,574,327). During three expert meetings, participants found consensus about calculated reference intervals for 18 tests and necessary partitioning in subcategories, based on sex, age, matrix and/or method. For two tests further evaluation of the reference interval and the study population were considered necessary. For glucose, the working group advised to adopt the clinical decision limit. Conclusions Using a ‘big-data’ approach we were able to determine traceable reference intervals for 18 general chemistry tests. Nationwide implementation of these established reference intervals has the potential to improve unequivocal interpretation of test results, thereby reducing patient harm.

[1]  N. Sattar,et al.  The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. , 2011, International journal of epidemiology.

[2]  L. Cohen [Asymptomatic hyperuricemia]. , 1982, Harefuah.

[3]  A. Dofferhoff,et al.  Pseudohyperkalemia and platelet counts. , 1991, The New England journal of medicine.

[4]  Ronald P. Stolk,et al.  Universal risk factors for multifactorial diseases-LifeLines : a three-generation population-based study , 2008 .

[5]  Kiyoshi Ichihara,et al.  Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values , 2013, Clinical chemistry and laboratory medicine.

[6]  M. Scott,et al.  Electrolytes and Blood Gases , 2012 .

[7]  Julian H Barth,et al.  Indirect methods for reference interval determination – review and recommendations , 2018, Clinical chemistry and laboratory medicine.

[8]  M. Panteghini,et al.  IFCC Primary Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes at 37C. Part 6. Reference Procedure for the Measurement of Catalytic Concentration of γ-Glutamyltransferase , 2002 .

[9]  F. Dekker,et al.  Prospective study of the effect of blood pressure on renal function in old age: the Leiden 85-Plus Study. , 2006, Journal of the American Society of Nephrology : JASN.

[10]  Marc H M Thelen,et al.  Expressing analytical performance from multi-sample evaluation in laboratory EQA , 2017, Clinical chemistry and laboratory medicine.

[11]  D. Bruns,et al.  State of Harmonization of 24 Serum Albumin Measurement Procedures and Implications for Medical Decisions. , 2017, Clinical chemistry.

[12]  K. Gorter,et al.  NHG-Standaard Artritis , 2009 .

[13]  J. Berg,et al.  Pathology Harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory , 2011, Annals of clinical biochemistry.

[14]  M. Plebani,et al.  Post-standardization of routine creatinine assays: are they suitable for clinical applications , 2017, Annals of clinical biochemistry.

[15]  R. Glynn,et al.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. , 1987, The American journal of medicine.

[16]  Rob T. P. Jansen The quest for comparability: Calibration 2000 , 2000 .

[17]  Lothar Siekmann,et al.  IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. , 2002, Clinical chemistry and laboratory medicine.

[18]  Lothar Siekmann,et al.  IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase. , 2002, Clinical chemistry and laboratory medicine.

[19]  Amadeo J Pesce,et al.  Reference intervals: an update. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[20]  Alicja R Rudnicka,et al.  Statin safety: a systematic review. , 2006, The American journal of cardiology.

[21]  A. Šimundić,et al.  Order of blood draw: Opinion Paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) , 2017, Clinical chemistry and laboratory medicine.

[22]  K. Adeli,et al.  Opinion Paper: Deriving Harmonised Reference Intervals – Global Activities , 2016, EJIFCC.

[23]  David M Bunk,et al.  Roadmap for harmonization of clinical laboratory measurement procedures. , 2011, Clinical chemistry.

[24]  Cas Weykamp,et al.  Systematic monitoring of standardization and harmonization status with commutable EQA-samples--five year experience from the Netherlands. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[25]  B. Wolffenbuttel,et al.  Sex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort Study , 2017, Endocrine connections.

[26]  D. Dietzen Amino Acids, Peptides, and Proteins , 2018 .

[27]  L. Punzi,et al.  Is it time to revise the normal range of serum uric acid levels? , 2014, European review for medical and pharmacological sciences.

[28]  Sverre Sandberg,et al.  Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine , 2015, Clinical chemistry and laboratory medicine.

[29]  Antony Barker,et al.  The case for common reference intervals. , 2004, The Clinical biochemist. Reviews.

[30]  M. Panteghini,et al.  IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C. Part 9: Reference procedure for the measurement of catalytic concentration of alkaline phosphatase , 2011, Clinical chemistry and laboratory medicine.

[31]  George Koumantakis,et al.  Harmonising adult and paediatric reference intervals in australia and new zealand: an evidence-based approach for establishing a first panel of chemistry analytes. , 2014, The Clinical biochemist. Reviews.

[32]  Gus Koerbin,et al.  Evidence-based approach to harmonised reference intervals. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[33]  Nutritional anaemias. Report of a WHO scientific group. , 1968, World Health Organization technical report series.

[34]  Carmen Perich,et al.  A category 1 EQA scheme for comparison of laboratory performance and method performance: An international pilot study in the framework of the Calibration 2000 project. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[35]  F. Ceriotti,et al.  IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. , 2006, Clinical chemistry and laboratory medicine.

[36]  E. Elinav,et al.  Low Alanine Aminotransferase Activity in Older People Is Associated with Greater Long‐Term Mortality , 2006, Journal of the American Geriatrics Society.

[37]  Cas Weykamp,et al.  The quest for equivalence of test results: the pilgrimage of the Dutch Calibration 2.000 program for metrological traceability , 2018, Clinical chemistry and laboratory medicine.

[38]  P. Hyltoft Petersen,et al.  The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties , 2004, Scandinavian journal of clinical and laboratory investigation.

[39]  BOULIN,et al.  [Classification and diagnosis of diabetes]. , 1953, Concours medical.

[40]  Lawrence A Leiter,et al.  Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management , 2015, European heart journal.

[41]  2. Classification and Diagnosis of Diabetes , 2014, Diabetes Care.

[42]  J. Henny,et al.  Reference intervals for serum creatinine concentrations: assessment of available data for global application. , 2008, Clinical chemistry.

[43]  Common reference intervals: the IFCC position. , 2009, Clinical biochemistry.

[44]  F. Blyth,et al.  The association of alanine transaminase with aging, frailty, and mortality. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[45]  Thomas Streichert,et al.  Pediatric reference intervals for alkaline phosphatase , 2017, Clinical chemistry and laboratory medicine.

[46]  Mario Plebani,et al.  Promoting clinical and laboratory interaction by harmonization. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[47]  J. Tate,et al.  Harmonising Adult Reference Intervals in Australia and New Zealand - the Continuing Story. , 2016, The Clinical biochemist. Reviews.

[48]  A. D. de Craen,et al.  Thyroid status, disability and cognitive function, and survival in old age. , 2004, JAMA.

[49]  Suzy L Wong,et al.  Biochemical marker reference values across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. , 2015, Clinical chemistry.

[50]  C. Weykamp,et al.  Harmonisation of seven common enzyme results through EQA , 2014, Clinical chemistry and laboratory medicine.

[51]  M. Epstein Aging and the kidney. , 1996, Journal of the American Society of Nephrology : JASN.

[52]  H. Baadenhuijsen,et al.  Indirect Estimation of Clinical Chemical Reference Intervals from Total Hospital Patient Data: Application of a Modified Bhattacharya Procedure , 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[53]  R. Glynn,et al.  Asymptomatic Hyperuricemia. Risks and Consequences in the Normative Aging Study , 1987 .

[54]  M. Rauh,et al.  Age- and sex-specific dynamics in 22 hematologic and biochemical analytes from birth to adolescence. , 2015, Clinical chemistry.

[55]  M. Visser,et al.  Trends in lifestyle among three cohorts of adults aged 55–64 years in 1992/1993, 2002/2003 and 2012/2013 , 2018, European journal of public health.

[56]  J. Tate,et al.  An update report on the harmonization of adult reference intervals in Australasia , 2018, Clinical chemistry and laboratory medicine.

[57]  A. Weverling-Rijnsburger,et al.  Total cholesterol and risk of mortality in the oldest old , 1997, The Lancet.